Binnacle Investments Inc Acadia Pharmaceuticals Inc Transaction History
Binnacle Investments Inc
- $137 Billion
- Q1 2025
A detailed history of Binnacle Investments Inc transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Binnacle Investments Inc holds 19 shares of ACAD stock, worth $287. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19Holding current value
$287% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ACAD
# of Institutions
350Shares Held
170MCall Options Held
795KPut Options Held
290K-
Baker Bros. Advisors LP New York, NY42.9MShares$649 Million8.72% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.2MShares$230 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$183 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY8.71MShares$132 Million2.61% of portfolio
-
Morgan Stanley New York, NY7.3MShares$110 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $2.45B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...